Episode Details

Back to Episodes
Engineered T cells suppress HIV & Twice-yearly HIV injection goes generic - News (May 13, 2026)

Engineered T cells suppress HIV & Twice-yearly HIV injection goes generic - News (May 13, 2026)

Published 1 week, 1 day ago
Description
Please support this podcast by checking out our sponsors:
- Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad
- Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad
- Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily


Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily

Today's topics:

Engineered T cells suppress HIV - Early trial data suggest modified CAR-T cells can suppress HIV to undetectable levels without daily antiretroviral drugs for up to nearly two years in some participants. Keywords: CAR-T, functional cure, viral reservoir, conditioning chemo, antiretrovirals.

Twice-yearly HIV injection goes generic - Unitaid says a South African lab will be selected to manufacture a generic lenacapavir, a twice-yearly injectable that could transform HIV prevention and treatment access. Keywords: lenacapavir, generic, South Africa, Unitaid, long-acting injection.

Targeted drug reshapes pancreatic cancer - A targeted pill called daraxonrasib delayed pancreatic cancer progression around eight to nine months on average in new trial results, far longer than standard chemotherapy. Keywords: pancreatic cancer, RAS mutation, targeted therapy, NEJM, survival quality of life.

Personalized vaccine for glioblastoma - A phase 1 personalized DNA vaccine for glioblastoma triggered immune responses with minimal serious side effects, showing encouraging survival compared with historical benchmarks. Keywords: glioblastoma, neoantigens, GNOS-PV01, Nature Cancer, immunotherapy.

AI handheld scope for screening - PrecisionView, a pen-sized AI-assisted endomicroscope, aims to scan larger tissue areas with cellular detail to help detect epithelial cancers earlier and guide biopsies. Keywords: endomicroscope, point-of-care, early detection, AI imaging, epithelial cancer.

Brain-guided hearing boosts chosen voice - Columbia researchers showed direct human evidence that brain signals can guide audio processing to amplify the voice a listener is focusing on, addressing the ‘cocktail party’ problem. Keywords: hearing loss, neural decoding, speech intelligibility, listening effort, future hearing aids.

US–Ukraine drone defense partnership - The U.S. and Ukraine have drafted an initial memorandum toward joint drone manufacturing and counter-drone cooperation, leveraging Ukraine’s battlefield-tested innovations. Keywords: drones, joint ventures, export controls, electronic warfare, Shahed.

Trump–Xi summit centered on AI - An analysis says Trump’s upcoming meeting with Xi Jinping will hinge on AI rivalry—chips, talent, deployment, and safety rules—more than classic tariff fights. Keywords: US–China, artificial intelligence, chips, talent flows, governance standards.

Israel creates Oct. 7 tribunal - Israel’s parliament approved a special tribunal for Palestinians accused of participating in the Oct. 7 attack, including authority to impose the death penalty. Keywords: Israel, tribunal, death penalty, fair trial concerns, Oct. 7.

Birth control pill at 66 - On the 66th anniversary of the first oral contraceptive approval, a new look back highlights how the pill c

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us